Hepatitis B virus X gene 1751 to 1764 mutations: implications for HBeAg status and disease Free

Abstract

A translational stop in the hepatitis B virus (HBV) precore codon 28 and specific changes in the core promoter region of the X gene have been suggested to influence the level of circulating HBeAg in patients. We analysed the core promoter region and precore sequences from 59 HBV strains (including 14 from the databank) of different genotypes and from patients with different HBeAg/anti-HBe patterns. The initiator and TATA elements for transcription of precore and pregenomic RNA were highly conserved. The majority of X gene deletions in the core promoter region would lead to translational frame-shifts and stops, truncating the C- terminal end of the X protein. We found significant associations between specific changes in core promoter positions 1762 to 1764, in precore codon 28, and absence of circulating HBeAg. For the core promoter mutations alone, this association was related to the apparent degree of liver damage (as estimated by alanine aminotransferase levels) at the time of sampling. Mutations at nucleotides 1762 and/or 1764 were often accompanied by point mutations at positions 1751 to 1755. Since mutations at nucleotide positions 1762 and 1764 have recently been shown by studies to suppress HBeAg production with a concomitant enhancement of virus production, disappearance of the HBeAg- positive phenotype associated with 1762 to 1764 mutations may thus have at least as much significance for the course of infection as HBeAg absence associated with precore codon 28 stop mutations. These observations are considered against a secondary structural model for the 3′ end of HBV pregenomic RNA which also predicts enhancement of virus replication after mutation at positions 1762 and 1764.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-78-6-1469
1997-06-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/78/6/9191945.html?itemId=/content/journal/jgv/10.1099/0022-1317-78-6-1469&mimeType=html&fmt=ahah

References

  1. Arii M., Takada S., Koike K. 1992; Identification of three essential regions of hepatitis B virus X protein for trans-activating function. Oncogene 7:397–403
    [Google Scholar]
  2. Barlet V., Zarski J. P., Thelu M. A., Bichard P., Seigneurin J. M. 1994; Different prevalence of precore mutants in five members of a hepatitis-B-virus-infected family: evidence for a precore variant type in an asymptomatic anti-HBs patient. Journal of Hepatology 21:797–805
    [Google Scholar]
  3. Buckwold V. E., Xu Z., Chen M., Yen T. S. B., Ou J.-H. 1996; Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. Journal of Virology 70:5845–5851
    [Google Scholar]
  4. Carman W. F., Jacyna M. R., Hadziyannis S., Karayiannis P., McGarvey M. J., Makris A., Thomas H. C. 1989; Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet ii:588–590
    [Google Scholar]
  5. Chen I. H., Huang C.-J., Ting L. P. 1995; Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus. Journal of Virology 69:3647–3657
    [Google Scholar]
  6. Feitelson M. 1994; Biology of hepatitis B virus variants. Laboratory Investigation 71:324–349
    [Google Scholar]
  7. Felsenstein J. 1993; PHYLIP: phylogeny inference package (version 3.5c). Distributed by the author Department of Genetics, University of Washington, Seattle, Wash., USA:
    [Google Scholar]
  8. Ganem D., Varmus H. E. 1987; The molecular biology of the hepatitis B viruses. Annual Review of Biochemistry 56:651–693
    [Google Scholar]
  9. Gotoh K., Mima S., Uchida T., Shikata T., Yoshizawa K., Irie M., Mizui M. 1995; Nucleotide sequence of hepatitis B virus isolated from subjects without serum anti-hepatitis B core antibody. Journal of Medical Virology 46:201–206
    [Google Scholar]
  10. Guidotti L. G., Matzke B., Pasquinelli C., Shoenberger J. M., Rogler C. E., Chisari F. V. 1996 Journal of Virology 70:7056–7061
    [Google Scholar]
  11. Higgins G., Bleasby A. J., Fuchs R. 1992; CLUSTALV: improved software for multiple sequence alignment. Computer Applications in the Biosciences 8:189–191
    [Google Scholar]
  12. Horikita M., Itoh S., Yamamoto K., Shibayama T., Tsuda F., Okamoto H. 1994; Differences in the entire nucleotide sequence between hepatitis B virus genomes from carriers positive for antibody to hepatitis B e antigen with and without active disease. Journal of Medical Virology 44:96–103
    [Google Scholar]
  13. Itoh Y., Takai E., Ohnuma H., Kitajima K., Tsuda F., Machida A., Mishiro S., Nakamura T., Miyakawa Y., Mayumi M. 1986; A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proceedings of the National Academy of Sciences USA: 839174–9178
    [Google Scholar]
  14. Kidd A. H., Kidd-Ljunggren K. 1996; A revised secondary structure model for the 3ʹ-end of hepatitis B virus pregenomic RNA. Nucleic Acids Research 24:3295–3301
    [Google Scholar]
  15. Kidd-Ljunggren K., Öberg M., Kidd A. H. 1995a; The hepatitis B virus X gene : analysis of functional domain variation and gene phylogeny using multiple sequences. Journal of General Virology 76:2119–2130
    [Google Scholar]
  16. Kidd-Ljunggren K., Ekdahl K., Öberg M., Kurathong S., Lolekha S. 1995b; Hepatitis B virus strains in Thailand: genomic variants in chronic carriers. Journal of Medical Virology 47:454–461
    [Google Scholar]
  17. Lambert C., Nassal M., Velhagen I., Zentgraf H., Schroder C. H. 1993; Precore-mediated inhibition of hepatitis B virus progeny DNA synthesis. Journal of Virology 67:3756–3762
    [Google Scholar]
  18. Laskus T., Rakela J., Tong M. J., Nowicki M. J., Mosley J. W., Persing D. H. 1994; Naturally occurring hepatitis B virus mutants with deletions in the core promoter region. Journal of Hepatology 20:837–841
    [Google Scholar]
  19. Li J. S., Tong S. P., Wen Y. M., Vitvitski L., Zhang Q., Trepo C. 1993; Hepatitis B virus genotype A rarely circulates as an HBe-minus mutant: possible contribution of a single nucleotide in the precore region. Journal of Virology 67:5402–5410
    [Google Scholar]
  20. Ljunggren K., Kidd A. H. 1991; Enzymatic amplification and sequence analysis of precore/core DNA in HBsAg-positive patients. Journal of Medical Virology 34:179–183
    [Google Scholar]
  21. Lok A. S. F., Akarca U., Greene S. 1994; Mutations in the precore region of hepatitis B virus serve to enhance the stability of the secondary structure of the pre-genome encapsidation signal. Proceedings of the National Academy of Sciences USA: 914077–4081
    [Google Scholar]
  22. Magnius L. O., Espmark L. Å. 1972; New specificities in Australia antigen positive sera distinct from Le Bouvier determinants. Journal of Immunology 109:1017–1021
    [Google Scholar]
  23. Milich D. R., Jones J. E., Hughes J. L., Price J., Raney A. K., McLachlan A. 1990; Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?. Proceedings of the National Academy of Sciences USA: 876599–6603
    [Google Scholar]
  24. Miller R. H., Robinson W. S. 1986; Common evolutionary origin of hepatitis B and retroviruses. Proceedings of the National Academy of Sciences USA: 832531–2535
    [Google Scholar]
  25. Okamoto H., Tsuda F., Sakugawa H., Sastrosoewignjo R. I., Imai I., Miyakawa Y., Mayumi M. 1988; Typing hepatitis B virus by homology in nucleotide sequence : comparison of surface antigen subtypes. Journal of General Virology 69:2575–2583
    [Google Scholar]
  26. Okamoto H., Tsuda F., Akahane Y., Sugai Y., Yoshiba M., Moriyama K., Tanaka T., Miyakawa Y., Mayumi M. 1994; Hepatitis B virus with mutations in the core promoter for an e-antigen phenotype in carriers with antibody to e antigen. Journal of Virology 68:8102–8110
    [Google Scholar]
  27. Repp R., Keller C., Borkhardt A., Csecke A., Schaefer S., Gerlich W. H., Lampert F. 1992; Detection of a hepatitis B virus variant with a truncated X gene and enhancer II. Archives of Virology 125:299–304
    [Google Scholar]
  28. Rossner M. T. 1992; Hepatitis B virus X-gene product: a promiscuous transcriptional activator. Journal of Medical Virology 36:101–117
    [Google Scholar]
  29. Sato S., Suzuki K., Akahane Y., Akamatsu K., Akiyama K., Yunomura K., Tsuda F., Tanaka T., Okamoto H., Miyakawa Y., Mayumi M. 1995; Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Annals of Internal Medicine 122:241–248
    [Google Scholar]
  30. Siddiqui A. 1991; Transcription of hepadnaviruses. In Molecular Biology ofthe Hepatitis B Virus pp 95–108 McLachlan A. Edited by Boca Raton: CRC Press;
    [Google Scholar]
  31. Takada S., Koike K. 1994; Three sites of the hepatitis B virus X protein cooperatively interact with cellular proteins. Virology 205:503–510
    [Google Scholar]
  32. Takada S., Kido H., Fukutomi A., Mori T., Koike K. 1994; Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor. Oncogene 9:341–348
    [Google Scholar]
  33. Takahashi K., Aoyama K., Ohno N., Iwata K., Akahane Y., Baba K., Yoshizawa H., Mishiro S. 1995; The precore/core promoter mutant (T1762A1764) of hepatitis B virus: clinical significance and an easy method for detection. Journal of General Virology 76:3159–3164
    [Google Scholar]
  34. Takeda K., Akahane Y., Suzuki H., Okamoto H., Tsuda F., Miyakawa Y., Mayumi M. 1990; Defects in the precore region of the HBV genome in patients with chronic hepatitis B after sustained seroconversion from HBeAg to anti-HBe induced spontaneously or with interferon therapy. Hepatology 12:1284–1289
    [Google Scholar]
  35. Tong S., Li J., Vitvitski L., Trepo C. 1990; Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region. Virology 176:596–603
    [Google Scholar]
  36. Uchida T., Gotoh K., Shikata T. 1995; Complete nucleotide sequences and the characteristics of two hepatitis B virus mutants causing serologically negative acute or chronic hepatitis B. Journal of Medical Virology 45:247–252
    [Google Scholar]
  37. Wu H.-L., Chen P.-J., Lin M.-H., Chen D.-S. 1991; Temporal aspects of major viral transcript expression in Hep G2 cells transfected with cloned hepatitis B virus DNA; with emphasis on the X transcript. Virology 185:644–651
    [Google Scholar]
  38. Yamamoto K., Horikita M., Tsuda F., Itoh K., Akahane Y., Yotsumoto S., Okamoto H., Miyakawa Y., Mayumi M. 1994; Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. Journal of Virology 68:2671–2676
    [Google Scholar]
  39. Yuh C.-H., Chang Y.-L., Ting L.-P. 1992; Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus. Journal of Virology 66:4073–4084
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-78-6-1469
Loading
/content/journal/jgv/10.1099/0022-1317-78-6-1469
Loading

Data & Media loading...

Most cited Most Cited RSS feed